Tarceva (Erlotinib) for injection is used for the treatment of patients with non-small cell lung cancer

TARCEVA is a kinase inhibitor indicated for • Maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. • Treatment of locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. • First-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer, in combination with gemcitabine.

Tarceva (Erlotinib) for injection suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Tarceva (Erlotinib) for injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Tarceva (Erlotinib) for injection medicine cost price in India.

The order for Tarceva (Erlotinib) for injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically it is used for NSCLC with either an EGFR exon 19 deletion (del19) or exon 21 (L858R) substitution mutation which has spread to other parts of the body.

TARCEVA® (erlotinib) tablets, oral Initial U.S. Approval: 2004

Generic Name: Erlotinib

Tablets: 25 mg, 100 mg and 150 mg.

TARCEVA (erlotinib

GET IN TOUCH
with Indian Pharma Network

Indian Pharma Network, Delhi provides access to TARCEVA (erlotinib) on the Named Patient Import basis in India.

Get Access To FDA Approved Drugs.

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used for non-small cell lung cancer, pancreatic cancer treatment. Brand Name "TARCEVA (erlotinib) tablets" or Generic Name "Erlotinib tablets" can be imported for personal use under "patient name basis" treatment in Delhi, Noida, Gurgaon, Mumbai, Chennai, Kolkatta, Bangalore, Jaipur, Chandigarh India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.

Indian Pharma Network (IPN), Delhi. India

IPN, Delhi is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India. IPN, New Delhi helps patient, providing solutions on how to get access of anti cancer medicines which is not available in India.

BRANCH OFFICE : NEW DELHI | BENGALURU | KOLKATA | LUCKNOW | JODHPUR

Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Saudi Arabia | South Africa

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Tarceva (Erlotinib) for injection suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Tarceva (Erlotinib) for injection on prescription and Import License in Patient's Name only.

For overseas patients, Tarceva (Erlotinib) for injection can be made available in Send your enquiry to find Tarceva (Erlotinib) for injection in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Tarceva (Erlotinib) for injection.

For Tarceva (Erlotinib) for injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Shilpa Medicare gets US FDA nod for its ANDA, Erlotinib tablets For More Details

FDA approves first-line Tecentriq plus chemotherapy for metastatic nonsquamous non-small cell lung cancer For More Details